Ibutilide fumarate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for ibutilide fumarate and what is the scope of patent protection?
Ibutilide fumarate
is the generic ingredient in two branded drugs marketed by Pfizer, Avet Lifesciences, Luitpold, and Mylan Institutional, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for ibutilide fumarate. Three suppliers are listed for this compound.
Summary for ibutilide fumarate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 5 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 1 |
Patent Applications: | 818 |
What excipients (inactive ingredients) are in ibutilide fumarate? | ibutilide fumarate excipients list |
DailyMed Link: | ibutilide fumarate at DailyMed |
Recent Clinical Trials for ibutilide fumarate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
St. Jude Medical | N/A |
Abbott Medical Devices | N/A |
Ball Memorial Hospital | N/A |
Pharmacology for ibutilide fumarate
Drug Class | Antiarrhythmic |
Anatomical Therapeutic Chemical (ATC) Classes for ibutilide fumarate
US Patents and Regulatory Information for ibutilide fumarate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Institutional | IBUTILIDE FUMARATE | ibutilide fumarate | INJECTABLE;INJECTION | 090643-001 | Jan 11, 2010 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Avet Lifesciences | IBUTILIDE FUMARATE | ibutilide fumarate | INJECTABLE;INJECTION | 204146-001 | Apr 1, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Luitpold | IBUTILIDE FUMARATE | ibutilide fumarate | INJECTABLE;INJECTION | 090240-001 | Jan 11, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ibutilide fumarate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | CORVERT | ibutilide fumarate | INJECTABLE;INJECTION | 020491-001 | Dec 28, 1995 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.